CASSAVA SCIENCES INC Logo

CASSAVA SCIENCES INC

Clinical-stage biotech developing treatments for Central Nervous System disorders.

SAVA | US

Overview

Corporate Details

ISIN(s):
US69562K5065 (+1 more)
LEI:
Country:
United States of America
Address:
6801 N CAPITAL OF TEXAS HIGHWAY, 78731 AUSTIN

Description

Cassava Sciences, Inc. is a clinical-stage biotechnology company that develops investigational treatments for Central Nervous System (CNS) disorders. The company's primary focus is on its lead drug candidate, simufilam, a proprietary oral small molecule. Simufilam is designed to modulate the activity of the filamin A (FLNA) protein, which is involved in regulating neuronal development. The development program for simufilam targets conditions such as tuberous sclerosis complex (TSC)-related epilepsy and other mTOR pathway disorders. Preclinical studies in TSC models have shown that simufilam may reduce seizure frequency, supporting plans for future clinical trials.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-05-13 22:15
FORM 4
English ZIP 7.0 KB
2024-05-13 22:14
FORM 4
English ZIP 7.1 KB
2024-05-13 22:13
FORM 4
English ZIP 6.9 KB
2024-05-13 22:11
FORM 4
English ZIP 7.1 KB
2024-05-13 22:05
FORM 4
English ZIP 7.0 KB
2024-05-10 22:39
FORM 10-Q
English ZIP 2.2 MB
2024-05-10 22:07
FORM 8-K
English ZIP 114.9 KB
2024-05-08 22:05
FORM 8-K
English ZIP 99.4 KB
2024-05-03 14:19 English ZIP 6.6 KB
2024-05-01 15:13
FORM 8-K
English ZIP 105.9 KB
2024-04-30 15:13
FORM 4
English ZIP 7.7 KB
2024-04-25 15:15
FORM 4
English ZIP 7.5 KB
2024-04-22 15:19
FORM 4
English ZIP 7.4 KB
2024-04-17 22:21
FORM 4
English ZIP 7.6 KB
2024-04-15 22:01
FORM 8-K
English ZIP 95.6 KB

Automate Your Workflow. Get a real-time feed of all CASSAVA SCIENCES INC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for CASSAVA SCIENCES INC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for CASSAVA SCIENCES INC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

GeneOne Life Science, Inc. Logo
Biopharmaceutical R&D company specializing in nucleic acid-based biomedicines.
South Korea
011000
Geneuro Logo
Develops therapies for neurological and autoimmune diseases by targeting HERVs.
Switzerland
GEM
GENFIT Logo
Develops therapies and diagnostics for patients with rare and severe liver diseases.
France
GNFT
GENFLOW BIOSCIENCES PLC Logo
A biotechnology company developing gene therapies that target the aging process.
United Kingdom
GENF
GENINCODE PLC Logo
Specializes in genetic risk assessment and prediction of cardiovascular disease.
United Kingdom
GENI
GENINUS Inc. Logo
A biotech company offering genomic analysis for precision medicine and drug development.
South Korea
389030
Genomed Spolka Akcyjna Logo
Biotechnology firm for genetic research and molecular diagnostics using NGS technology.
Poland
GEN
A molecular diagnostics company developing tests for the early detection of cancer.
South Korea
228760
Genomic Vision Logo
Provides DNA analysis and quality control for bioproduction and gene therapy.
France
GV
genOway Logo
Designs and develops genetically modified preclinical models for research.
France
ALGEN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.